Found: 6
Select item for more details and to access through your institution.
Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.
- Published in:
- Journal of Neurochemistry, 2015, v. 133, n. 2, p. 266, doi. 10.1111/jnc.12960
- By:
- Publication type:
- Article
Molecular docking and dynamic simulation study to explore quercetin as a multi-potent candidate against gliomas.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2021, v. 20, n. 4, p. 815, doi. 10.4314/tjpr.v20i4.23
- By:
- Publication type:
- Article
Designing dual inhibitors for the treatment of Alzheimer’s disease as well as Type 2 diabetes mellitus via pharmacoinformatics approach: A step towards better medication for diabetes-associated neurological disorder.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2020, v. 19, n. 6, p. 1233, doi. 10.4314/tjpr.v19i6.18
- By:
- Publication type:
- Article
Infantile exposure to lead and late-age cognitive decline: Relevance to AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 2, p. 187, doi. 10.1016/j.jalz.2013.02.012
- By:
- Publication type:
- Article
Energy drinks and population health: consumption pattern and adverse effects among Saudi population.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Current Status of Brain Tumor in the Kingdom of Saudi Arabia and Application of Nanobiotechnology for Its Treatment: A Comprehensive Review.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 5, p. 421, doi. 10.3390/life11050421
- By:
- Publication type:
- Article